Immunohistological analyses of both PAR1 and Etk/Bmx showed little staining in comedo DCIS and ductal carcinoma in situ, but high levels of staining in IDC and lobular carcinoma (Fig. 5D; Table 1). Here, MARK2 is linked to breast lobular carcinoma.